Rising incidence and demographics of hepatocellular carcinoma in the USA: What does it mean?

Expert Review of Gastroenterology and Hepatology

Volumn 5, Issue 3, 2011, Pages 365-370

  Shaw, Joshua J ^a   Shah, Shimul A ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

cirrhosis; hepatitis C; hepatocellular carcinoma; liver transplantation; obesity

Indexed keywords

ALPHA FETOPROTEIN; HEPATITIS B VACCINE;

AGE DISTRIBUTION; ALCOHOL ABUSE; BLOOD TRANSFUSION; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER REGISTRY; CANCER SCREENING; CLINICAL FEATURE; DEMOGRAPHY; DIABETES MELLITUS; ETHNICITY; GEOGRAPHIC DISTRIBUTION; HEPATITIS B; HEPATITIS C; HUMAN; LIVER CELL CARCINOMA; METABOLIC SYNDROME X; NONALCOHOLIC FATTY LIVER; OBESITY; PROTEIN BLOOD LEVEL; REVIEW; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; SURVIVAL TIME; UNITED STATES; VACCINATION;

CARCINOMA, HEPATOCELLULAR; HUMANS; INCIDENCE; LIVER NEOPLASMS; PROGNOSIS; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; UNITED STATES;

EID: 79958267131     PISSN: 17474124     EISSN: 17474132     Source Type: Journal    
DOI: 10.1586/egh.11.20     Document Type: Review

References (38)

1. Parkin DM, Bray F, Ferlay J, et al. Estimating the world cancer burden: GLOBOCAN 2000. Int. J. Cancer 94, 153-156 (2001). (Pubitemid 32911406)
2. El-Serag HB, Davila JA, Petersen NJ, et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann. Intern. Med. 139, 817-823 (2003).
3. London WT, McGlynn KA. Liver cancer. In: Cancer Epidemiology and Prevention (3rd Edition). Schottenfeld D, Fraumeni JF Jr (Eds). Oxford University Press, NY, USA, 763-786 (2006).
4. Espey DK, Wu XC, Swan J, et al. Annual report to the nation on the status of cancer, 1975-2004, featuring cancer in American Indians and Alaska Natives. Cancer 110, 2119-2152 (2007). (Pubitemid 350100734)
5. El-Serag HB. Hepatocellular carcinoma: recent trends in the United States. Gastroenterology 127(5 Suppl. 1), S27-S34 (2004). (Pubitemid 39423367)
6. Shah SA, Cleary SP, Tan JC, et al. An analysis of resection vs transplantation for early hepatocellular carcinoma: defining the optimal therapy at a single institution. Ann. Surg. Oncol. 14(9), 2608-2614 (2007). (Pubitemid 47389575)
7. Shah SA, Greig PD, Gallinger S, et al. Factors associated with early recurrence after resection for hepatocellular carcinoma and outcomes. J. Am. Coll. Surg. 202(2), 275-283 (2006). (Pubitemid 43112487)
8. El-Serag HB, Davila JA, Petersen NJ et al. The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update. Ann. Intern. Med. 139(10), 817-823 (2003).
9. Shah SA, Smith JP, Li YF, Ng SC, Carroll JE, Tseng JF. Underutilization of therapy for hepatocellular carcinoma in the Medicare population. Cancer 117(5), 1019-1026 (2011).
10. Schottenfeld D, Fraumeni JF (Eds). Cancer Epidemiology and Prevention (3rd Edition). Oxford University Press, NY, USA (2006).
11. El-Serag HB, Mason AC. Risk factors for the rising rates of primary liver cancer in the United States. Arch. Intern. Med. 160(21), 3227-3230 (2000)
12. Hong K, Chaplin TM, Bergquist K, Sinha R. Gender differences in response to emotional stress: an assessment across subjective, behavioral and physiological domains and relations to alcohol craving. Alcohol Clin. Exp. Res. 32(7), 1242-1250 (2008).
13. Anthony JC, Helzer JE. Syndromes of drug abuse and dependence. In: Psychiatric Disorders in America. Robins LN, Regier DA (Eds). The Free Press/Macmillan, NY, USA, 116-154 (1991).
14. Wang SH, Yeh SH, Lin WH, Wang HY, Chen DS, Chen PJ. Identification of androgen response elements in the enhancer I of hepatitis B virus: a mechanism for sex disparity in chronic hepatitis B. Hepatology. 50(5), 1392-1402 (2009).
15. Barazani Y, Hiatt JR, Tong MJ, et al. Chronic viral hepatitis and hepatocellular carcinoma. World J. Surg. 31, 1243-1248 (2007). (Pubitemid 47029929)
16. Degos F, Christidis C, Ganne-Carrie F et al. Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death. Gut 47, 131-136 (2000). (Pubitemid 30430422)
17. Armstrong GL, Wasley A, Simard EP, et al. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann. Intern. Med. 144, 705-714 (2006). (Pubitemid 46780630)
18. Wasley A, Grytdal S, Gallagher K: Surveillance for acute viral hepatitis - United States, 2006. MMWR Surveill. Summ. 57(2), 1-24 (2008).
19. Sherman M. Hepatocellular carcinoma: epidemiology, risk factors, and screening. Semin. Liver Dis. 25, 143-154 (2005). (Pubitemid 40781067)
20. El-Serag HB, Mason AC. Rising incidence of hepatocellular carcinoma in the United States. N. Engl. J. Med. 340, 745-750 (1999). (Pubitemid 29114292)
21. Wasley A. The prevalence of hepatitis B virus infection in the United States in the era of vaccination. J. Infect. Dis. 202, 192-201 (2010).
22. Papatheodoridis GV, Lampertico P, Manolakopoulos S, Lok A. Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review. J. Hepatol. 53, 348-356 (2010).
23. Morgan TR, Mandayam S, Jamal MM. Alcohol and hepatocellular carcinoma. Gastroenterology 127(5 Suppl. 1), S87-S96 (2004). (Pubitemid 39423374)
24. LaVallee RA, Williams GD, Yi H. Apparent per capita ethanol consumption for the United States, 1850-2002. [Gallons of ethanol, based on population age 15 and older prior to 1970 and on population age and older thereafter]. National Institute on Alcohol Abuse and Alcoholism. January 2005.
25. Ford ES, Giles WH, Mokdad AH. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27, 2444-2449 (2004). (Pubitemid 39281399)
26. Lu SN, Lin TM, Chen CJ, et al. A case-control study of primary hepatocellular carcinoma in Taiwan. Cancer 62, 2051-2055 (1988). (Pubitemid 18261836)
27. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N. Engl. J. Med. 348, 1625-1638 (2003). (Pubitemid 36459468)
28. Chen CL, Yang HI, Yang WS, et al. Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: a follow-up study in Taiwan. Gastroenterology 135(1), 111-121 (2008).
29. Adami HO, Chow WH, Nyren O, et al. Excess risk of primary liver cancer in patients with diabetes mellitus. J. Natl Cancer Inst. 88, 1472-1477 (1996). (Pubitemid 26340049)
30. Bugianesi E. Non-alcoholic steatohepatitis and cancer. Clin. Liver Dis. 11, 191-207 (2007). (Pubitemid 46829971)
31. Lawson DH, Gray JM, McKillop C, Clarke J, Lee FD, Patrick RS. Diabetes mellitus and primary hepatocellular carcinoma. Q. J. Med. 61, 945-955 (1986). (Pubitemid 17181316)
32. Adams LA, Sanderson S, Lindor KD, Angulo P. The histological course of nonalcoholic fatty liver disease: a longitudinal study of 103 patients with sequential liver biopsies. J. Hepatol. 42, 132-138 (2005). (Pubitemid 40038911)
33. Fassio E, Alvarez E, Dominguez N, Landeira G, Longo C. Natural history of nonalcoholic steatohepatitis: a longitudinal study of repeat liver biopsies. Hepatology 40, 820-826 (2004). (Pubitemid 39288114)
34. Ratziu VD, Bonyhay L, Di Martino V et al. Survival, liver failure, and hepatocellular carcinoma in obesity-related cryptogenic cirrhosis. Hepatology 35, 1485-1493 (2002). (Pubitemid 34966903)
35. Parkin DM, Bray F, Ferlay J, et al. WHO. The global burden of disease. 2004 update www.who.int/healthinfo/global-burden- disease/GBD-report-2004update- full. pdf
36. Ries LAG, Melbert D, Krapcho M, et al. (Eds). SEER Cancer Statistics Review, 1975-2005. National Cancer Institute, Bethesda, MD, USA (2008) http://seer.cancer.gov/csr/1975-2005
37. WHO. Hepatitis B www.who.int/mediacentre/factsheets/ fs204/en/index.html
38. SEER Stat Fact Sheets: Liver and Intrahepatic Bile Duct http://seer.cancer.gov/statfacts/html/ livibd.html